{
    "nct_id": "NCT03194906",
    "official_title": "Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors: A Pilot Study",
    "inclusion_criteria": "* Age 6 years to 21 years at time of study enrollment\n* Diagnosis of localized low grade glioma [e.g., pilocytic astrocytoma, optic pathway glioma, ogligodendroglioma, ganglioglioma, pleomorphic xanthoastrocytoma (PXA)], craniopharyngioma, ependymoma, or germ cell tumor\n* Initiating focal cranial radiation therapy (photon or proton)\n* Laboratory tests [transaminases (ALT, AST, ALP), BUN and creatinine not greater than twice normal] and normal ECG\n* Speak, read and understand English sufficiently to complete study assessments\n* Adequate vision and hearing for valid completion of study measures\n* Negative Î²HCG pregnancy test among females of childbearing age\n* Participant must be able to swallow pills (psychology staff will be available to assist with pill swallowing training if needed)\n* Parent/Legal guardian available and able to speak, read and understand English\nHealthy volunteers allowed\nMust have minimum age of 6 Years\nMust have maximum age of 21 Years",
    "exclusion_criteria": "* Medical disorder that would endanger subject's well-being (e.g., uncorrected hypothyroidism, cardiac arrhythmia, hypertension requiring treatment, sick sinus syndrome, prolonged QTc)\n* History of significant neurological disease including poorly controlled seizures (i.e., > 1 seizure per month; anti-epileptic medications are acceptable), stroke, or head injury with loss of consciousness\n* Psychiatric condition that would preclude or take precedence over study participation (e.g., active psychosis, suicidal ideation)\n* IQ below 70 based on baseline/screening assessment\n* Treatment with psychotropic medication (psychostimulant, antidepressant, anxiolytic, antipsychotic) within the past two weeks, unless being prescribed specifically as an anti-emetic\n* History of substance abuse\n* History of hypersensitivity or reaction to NMDA receptor antagonists\n* History of prior cranial radiation therapy",
    "miscellaneous_criteria": ""
}